The cell and gene therapy CDMO market is experiencing significant growth, driven by the increasing number of cell and gene therapy candidates advancing through clinical development and ...

Global Contract Development and Manufacturing Organizations (CDMOs) are employing divergent investment strategies to seize ...

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

PRINCETON, N.J., April 30, 2026 /PRNewswire/ -- Made Scientific, a U.S.-based contract development and manufacturing organization (CDMO) specializing in cell therapies, today announced the continued ...

The MarketWatch News Department was not involved in the creation of this content. SINGAPORE, March 11, 2026 /PRNewswire/ -- Locus Cell Co., Ltd. ("Locus Cell"), a Taiwan-based cell and gene therapy ...

Officials at Mytos, which is automating cell manufacturing, launched its automated contract development and manufacturing organization (CDMO), offering to overcome one of what they call regenerative ...

The U.S. Radiopharmaceutical CDMO Market is projected to grow from USD 1.29 Billion in 2025 to USD 3.00 Billion by 2035, while Europe is expected to expand from USD 1.09 Billion to USD 3.24 Billion, ...

Charles River Laboratories is continuing its run of layoffs by announcing the closure of its cell therapy contract development and manufacturing organization (CDMO) site in Hanover, Maryland that will ...

The future of cell and gene therapy may be defined less by discoveries and more by how the industry connects research and ...

DURHAM, N.C.--(BUSINESS WIRE)--Kincell Bio, a leading US cell therapy CDMO, is excited to announce a partnership with Moonlight Bio, Inc., a Seattle-based biotech company pioneering advanced T cell ...

On June 30, HLB Peptide announced that it has signed a main contract for contract development and manufacturing organization (CDMO) services with Pept ...